Latest Business News

FILE - In this July 1, 2020, file photo, Instacart worker Saori Okawa loads groceries into her car for home delivery in San Leandro, Calif. There are plenty of jobs in the gig work arena. To stay safe and find the right fit, evaluate the risks, expand your search beyond the obvious roles and calculate how much you’ll really make after taking expenses such as fees and insurance into account. (AP Photo/Ben Margot, File)

Millennial Money: Picking a pandemic side gig takes hustle

Oct. 27, 2020 8:45 AM EDT

Side gig. Side job. Side hustle. It goes by many names and serves many purposes. For some, it’s a way to keep the lights on. For others, it’s an opportunity to save for a goal or follow a passion. Since the onset of the COVID-19 pandemic, millions of Americans have become unemployed. Many are...

Health service member calling for a general strike and demanding more labor protection on her job, in Pamplona, northern Spain, Tuesday, Oct. 27, 2020, while Spain suffer a second strong pandemic crisis by COVID-19.(AP Photo/Alvaro Barrientos)

The Latest: Spain doctors stage walkout over health system

Oct. 27, 2020 8:44 AM EDT

MADRID — Spanish doctors are staging their first national walkout in 25 years to protest what they say are poor working conditions and the weakened state of the national public health system. The 24-hour strike was called by the State Confederation of Medical Unions, which wants health authorities to...

FILE - This is an April 26, 2017, file photo showing Eli Lilly corporate headquarters in Indianapolis. Eli Lilly continues to back a potential COVID-19 treatment despite research showing that it may not work on hospitalized patients. The drugmaker said Tuesday, Oct. 27, 2020, that It remains confident that its drug may stop COVID from developing in other patients. (AP Photo/Darron Cummings, File)

Lilly stays confident in possible COVID drug after setback

Oct. 27, 2020 8:44 AM EDT

INDIANAPOLIS (AP) — Eli Lilly continues to back a potential COVID-19 treatment despite research showing that it may not work on hospitalized patients. The drugmaker said Tuesday it remains confident that its drug may stop COVID from developing in other patients. Researchers are still studying the drug in...

An elementary school student, wearing a face mask as a precaution against the coronavirus outbreak, receives a Td vaccine shot from a health worker during a free vaccination service for schoolchildren in Jakarta, Indonesia,Tuesday, Oct. 27, 2020. (AP Photo/Achmad Ibrahim)

Asia Today: Thailand: Woman probably infected in quarantine

Oct. 27, 2020 8:42 AM EDT

BANGKOK (AP) — Health officials in Thailand said Tuesday it is likely that a French woman who earlier this month tested positive for the coronavirus became infected when she stayed under quarantine at a hotel near Bangkok. The 57-year-old woman tested positive after she and her family flew on Oct. 15 from...

Orders for big-ticket manufactured goods increased 1.9% in September with a key business investment category up as well

Oct. 27, 2020 8:39 AM EDT
WASHINGTON (AP) — Orders for big-ticket manufactured goods increased 1.9% in September with a key business investment category up as well.

Lithuania upset over soon-to-open Belarus nuke plant

Oct. 27, 2020 8:35 AM EDT

VILNIUS, Lithuania (AP) — The Baltic nation of Lithuania sent a protest note Tuesday to Belarus over a planned nuclear power plant close to their border that is scheduled to start operating in early November. The Astravyets nuclear power plant, 40 kilometers (25 miles) south of Vilnius, Lithuania’s...

FILE- This May 1, 2018, file photo shows Merck corporate headquarters in Kenilworth, N.J.  Surging sales of cancer medicines and reduced spending helped Merck overcome a big hit from the coronavirus pandemic and increase its profit 12% in the second quarter. The  drugmaker on Friday, July 31, 2020,  increased its financial forecast for the year, all while it’s investing in development of two experimental vaccines and a possible treatment for COVID-19.  (AP Photo/Seth Wenig, File)

Strong sales of drugs, vaccines, propel Merck in 3Q

Oct. 27, 2020 8:24 AM EDT

KENILWORTH, N.J. (AP) — Drugmaker Merck boosted its third-quarter profit by 55% and blew past Wall Street expectations, due to slightly higher sales, restrained spending and a small, one-time gain. The Kenilworth, New Jersey, company said it's making progress on three efforts to combat the coronavirus...

FILE - In this Sept. 18, 2019, photo a Puckett Machinery Company technician walks past a new heavy duty Caterpillar excavator that awaits modification at Puckett Machinery Company in Flowood, Miss. Caterpillar is reporting a third-quarter profit of $668 million and topped most expectations, though demand for its equipment is being driven down by the pandemic. The Deerfield, Illinois, company reported a profit Tuesday, Oct. 27, 2020, of $1.22 per share. (AP Photo/Rogelio V. Solis, File)

As pandemic depresses demand, Caterpillar muscles through 3Q

Oct. 27, 2020 8:22 AM EDT

Caterpillar’s sales fell 23% in the third quarter as the pandemic throttled demand for construction equipment and a trade war with China continues to create headwinds. The company still managed to top Wall Street expectations, despite rising COVID-19 infections that hamper almost all sectors, including...

FILE - In this Jan. 20, 2011, file photo, AMD chips are displayed at the Micro Center computer store in Santa Clara, Calif. AMD is buying processing platform developer Xilinx in an all-stock deal valued at $35 billion. (AP Photo/Paul Sakuma, File)

AMD buys Xilinx for $35B, creating Silicon Valley chip giant

Oct. 27, 2020 7:50 AM EDT

SAN JOSE, Calif. (AP) — AMD is buying Xilinx for $35 billion in an all-stock deal that will combine the two Silicon Valley chip makers. The deal announced Tuesday puts AMD in a place it wants to be; competing more fiercely with Intel. Xilinx stockholders will receive 1.7234 shares of AMD stock for each...

Pfizer signs are seen out front of the Pfizer Research & Development Laboratories Wednesday, July 22, 2020, in Groton, Conn.  Pfizer on Tuesday, July 28,  reported a 32% plunge in second-quarter profit, as the global coronavirus pandemic limited marketing of and new prescriptions for its medicines. Still, the biggest U.S. drugmaker posted a solid profit and nudged up parts of its 2020 financial forecast. (AP Photo/Stew Milne)

Pfizer tops 3Q earnings views, makes progress on COVID shot

Oct. 27, 2020 7:49 AM EDT

Drugmaker Pfizer saw its third-quarter profit plunge 71%, mainly due to an $8.1 billion gain a year earlier from selling its consumer health care business to a GlaxoSmithKline joint venture, but managed to top Wall Street expectations. Meanwhile, the New York-based company on Tuesday said disruptions from the...